2
Most read
3
Most read
10
Most read
THIS POWERPOINT WILL ANSWER
THESE QUESTIONS:
• WHAT IS MULTIPLE SCLEROSIS?
• THE SYMPTOMS
• WHAT MIGHT CAUSE IT?
• SPECIFIC STRUCTURES AND
FUNCTIONS
• CURRENT TREATMENTS
• HISTORY
• WHO GETS EFFECTED?
• LIFE EXPECTANCY
Multiple sclerosis
What is Multiple Sclerosis?
 Multiple sclerosis is an unpredictable, disabling
disease of the central nervous system that disrupts
the flow of information within the brain, and
between the brain and body.
Symptoms
 Fatigue
 Walking difficulties
 Numbness
 Weakness
 Spasticity
 Vision problems
 Pain
 Depression
 Emotional changes
These Symptoms are the most common and around 80% of people who are
diagnosed with Multiple Sclerosis have shown these symptoms
What might cause it?
 The cause of MS is still unknown – most scientists
believe the disease is triggered by an unidentified
environmental factor in a person who is genetically
unprepared to respond.
STRUCTURE AND FUNCTIONS
 MS is caused by damage to the myelin sheath. This
sheath is the protective covering that surrounds
nerve cells. When this nerve covering is damaged,
nerve signals slow down or stop.
 The nerve damage is caused by inflammation.
Inflammation occurs when the body's own immune
cells attack the nervous system. This can occur along
any area of the brain, optic nerve, and spinal cord.
Who gets affected?
 MS occurs in most ethnic groups, including African-
Americans, Asians and Hispanics/Latinos, but is more
common in Caucasians of northern European ancestry.
 MS most commonly effects people from 20 to 50 years of
age
 The average person in the United States has about one in
750 (.1%) chance of developing MS
Current Treatments
 Currently, people with MS use a lot of medication
depending on what kind of symptoms they have.
 Today multiple sclerosis (MS) is not a curable
disease. Effective strategies can help modify or slow
the disease, treat attacks, manage symptoms,
improve function and safety, and address emotional
health.
History
 The history of multiple sclerosis (MS) is a detective
story spanning more than a century.
 Scientifically, MS was among the first diseases to be
described.
 Further knowledge of MS could not advance without
better understanding of biology and better research
tools
 In 1968, Scientist Jean Martin Charcot discovered
this disease when doing on an autopsy.
Life Expectancy
 The University of Maryland Medical Center reports
that the majority of MS patients will experience a
normal (or almost normal) life span
 People with MS tend to die from many of the same
conditions that people without MS die from,
including cancer and heart disease.
 Severe MS (Extremely rare) will cause discomfort,
vertigo, overwhelming, and inconvenience. This
leads to more suicide rates.
Citation
 http://www.nationalmssociety.org
 http://www.healthline.com/health/multiple-
sclerosis/prognosis-and-life-
expectancy#NotFatal,butNoCure1

More Related Content

PPTX
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
PPTX
Multiple sclerosis
PPTX
Multiple sclerosis
PPT
Multiple sclerosis
PPT
Multiple Sclerosis ppt
PPTX
Nmo ppt
 
PPT
Multiple sclerosis
PPTX
Motor Neuron Disease
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
Multiple sclerosis
Multiple sclerosis
Multiple sclerosis
Multiple Sclerosis ppt
Nmo ppt
 
Multiple sclerosis
Motor Neuron Disease

What's hot (20)

PPTX
Approach to Peripheral Neuropathy
PPTX
1.multiple sclerosis
PPTX
multiple sclerosis
PPTX
Approach to Ataxia
PPT
Multiple sclerosis.ppt
PPTX
Multiple sclerosis by Dr. Basil B. Tumaini
PPTX
Multiple Sclerosis SEMINAR
PPTX
Multiple sclerosis
PPTX
Neurosyphilis
PPTX
PPTX
CIDP recent advances
PPTX
Chronic inflammatory demyelinating Polyradiculoneuropathy
PPT
Multiple Sclerosis
PPT
Peripheral neuropathy
PPTX
CIDP guidelines
PDF
Spinocerebellar ataxia
PDF
Progressive multifocal leukoencephalopathy (PML)
PPTX
Spinocerebellar ataxia
PPTX
Motor neuron disease
Approach to Peripheral Neuropathy
1.multiple sclerosis
multiple sclerosis
Approach to Ataxia
Multiple sclerosis.ppt
Multiple sclerosis by Dr. Basil B. Tumaini
Multiple Sclerosis SEMINAR
Multiple sclerosis
Neurosyphilis
CIDP recent advances
Chronic inflammatory demyelinating Polyradiculoneuropathy
Multiple Sclerosis
Peripheral neuropathy
CIDP guidelines
Spinocerebellar ataxia
Progressive multifocal leukoencephalopathy (PML)
Spinocerebellar ataxia
Motor neuron disease
Ad

Similar to Multiple sclerosis (20)

PDF
Multiple Sclerosis (MS)
PPTX
Austin Journal of Multiple Sclerosis & Neuroimmunology
PPTX
Austin Journal of Multiple Sclerosis & Neuroimmunology
PPTX
Austin Journal of Clinical Immunology
PPTX
Austin Journal of Multiple Sclerosis & Neuroimmunology
PPTX
Austin Journal of Multiple Sclerosis & Neuroimmunology
PPTX
Multiple sclerosis
DOCX
Multiple sclerosis
PPT
Multiple sclerosis
PPT
MSOverview_NursingStudents.ppt
PPTX
Multiple Sclerosis
PPTX
Multiple Sclerosis (MS)
PPT
MS: In a Nutshell
PPT
Multiple Sclerosis
PPT
Multiple Sclerosis
PPTX
Multiple sclerosis-1.pptx
PPTX
Multiple Sclerosis A serious Neurological Condition
PPTX
Multiple sclerosis
PPTX
Multiple sclerosis
PDF
The Predominance Of Multiple Sclerosis (MS)
Multiple Sclerosis (MS)
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Clinical Immunology
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology
Multiple sclerosis
Multiple sclerosis
Multiple sclerosis
MSOverview_NursingStudents.ppt
Multiple Sclerosis
Multiple Sclerosis (MS)
MS: In a Nutshell
Multiple Sclerosis
Multiple Sclerosis
Multiple sclerosis-1.pptx
Multiple Sclerosis A serious Neurological Condition
Multiple sclerosis
Multiple sclerosis
The Predominance Of Multiple Sclerosis (MS)
Ad

Recently uploaded (20)

PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
Calcified coronary lesions management tips and tricks
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PPTX
preoerative assessment in anesthesia and critical care medicine
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
Acute Coronary Syndrome for Cardiology Conference
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PDF
Transcultural that can help you someday.
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
thio and propofol mechanism and uses.pptx
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
09. Diabetes in Pregnancy/ gestational.pptx
Wheat allergies and Disease in gastroenterology
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Calcified coronary lesions management tips and tricks
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
preoerative assessment in anesthesia and critical care medicine
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
Acute Coronary Syndrome for Cardiology Conference
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PEADIATRICS NOTES.docx lecture notes for medical students
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Transcultural that can help you someday.
AGE(Acute Gastroenteritis)pdf. Specific.
thio and propofol mechanism and uses.pptx
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
OSCE Series ( Questions & Answers ) - Set 6.pdf

Multiple sclerosis

  • 1. THIS POWERPOINT WILL ANSWER THESE QUESTIONS: • WHAT IS MULTIPLE SCLEROSIS? • THE SYMPTOMS • WHAT MIGHT CAUSE IT? • SPECIFIC STRUCTURES AND FUNCTIONS • CURRENT TREATMENTS • HISTORY • WHO GETS EFFECTED? • LIFE EXPECTANCY Multiple sclerosis
  • 2. What is Multiple Sclerosis?  Multiple sclerosis is an unpredictable, disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body.
  • 3. Symptoms  Fatigue  Walking difficulties  Numbness  Weakness  Spasticity  Vision problems  Pain  Depression  Emotional changes These Symptoms are the most common and around 80% of people who are diagnosed with Multiple Sclerosis have shown these symptoms
  • 4. What might cause it?  The cause of MS is still unknown – most scientists believe the disease is triggered by an unidentified environmental factor in a person who is genetically unprepared to respond.
  • 5. STRUCTURE AND FUNCTIONS  MS is caused by damage to the myelin sheath. This sheath is the protective covering that surrounds nerve cells. When this nerve covering is damaged, nerve signals slow down or stop.  The nerve damage is caused by inflammation. Inflammation occurs when the body's own immune cells attack the nervous system. This can occur along any area of the brain, optic nerve, and spinal cord.
  • 6. Who gets affected?  MS occurs in most ethnic groups, including African- Americans, Asians and Hispanics/Latinos, but is more common in Caucasians of northern European ancestry.  MS most commonly effects people from 20 to 50 years of age  The average person in the United States has about one in 750 (.1%) chance of developing MS
  • 7. Current Treatments  Currently, people with MS use a lot of medication depending on what kind of symptoms they have.  Today multiple sclerosis (MS) is not a curable disease. Effective strategies can help modify or slow the disease, treat attacks, manage symptoms, improve function and safety, and address emotional health.
  • 8. History  The history of multiple sclerosis (MS) is a detective story spanning more than a century.  Scientifically, MS was among the first diseases to be described.  Further knowledge of MS could not advance without better understanding of biology and better research tools  In 1968, Scientist Jean Martin Charcot discovered this disease when doing on an autopsy.
  • 9. Life Expectancy  The University of Maryland Medical Center reports that the majority of MS patients will experience a normal (or almost normal) life span  People with MS tend to die from many of the same conditions that people without MS die from, including cancer and heart disease.  Severe MS (Extremely rare) will cause discomfort, vertigo, overwhelming, and inconvenience. This leads to more suicide rates.